ClinicalTrials.govpublic full text
Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory Leukemias
refractory leukemia, relapsed leukemia, acute myelogenous leukemia, acute lymphoblastic leukemia, adult t-cell leukemia/lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 184921
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.